
|Articles|August 2, 2003
- Pharmaceutical Technology-08-02-2003
- Volume 27
- Issue 8
New FDA Initiatives Aim to Spur Innovation
Author(s)Jill Wechsler
Manufacturers face challenges from FDA's plans to streamline the drug review and development processes aimed to spur innovation.
Advertisement
Articles in this issue
over 22 years ago
BIO Updateover 22 years ago
Designing Transfer Carts for Class 100 Conditionsover 22 years ago
An Update on Osmotic Drug Deliveryover 22 years ago
Interphex Serves as a Showcase for New Materials and Machinesover 22 years ago
August 2003over 22 years ago
In the Spotlight August 2003Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
A Year of Advancements in the Treatment of Cancer
2
Full Autonomy Is a ‘No-Go Zone’: Setting Parameters for Agentic AI in Pharma
3
PharmTech’s Top 10 Articles of 2025
4
The Year of the Tariff: Pharmaceutical Supply Chain Reimagined in 2025
5




